NCT00759226View on ClinicalTrials.gov

Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

July 31, 2002

Primary Completion Date

July 31, 2005

Study Completion Date

August 31, 2007

Conditions
Esophageal Cancer
Interventions
DRUG

Gemcitabine

Gemcitabine 1000 mg/m2 (30 min)

DRUG

Cisplatin

Cisplatin 30 mg/m2 (90 min)

DRUG

5-FU

5-FU 750 mg/m2 (24h CI)

DRUG

Folinic Acid

Folinic Acid 200 mg/m2 (30 min)

Trial Locations (1)

13353

Charite Universitätsmedizin Berlin, Berlin

All Listed Sponsors
collaborator

Eli Lilly and Company

INDUSTRY

collaborator

medac GmbH

INDUSTRY

lead

CONKO-Studiengruppe

OTHER

NCT00759226 - Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer | Biotech Hunter | Biotech Hunter